ECM
XBIT icon

ExodusPoint Capital Management’s XBiotech XBIT Stock Holding History

ExodusPoint Capital Management’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-16,177
Closed -$132K – 2046
2024
Q1 		$132K Buy
+16,177
New +$92.7K ﹤0.01% 1404
2021
Q2 		– Sell
-12,811
Closed -$220K – 2870
2021
Q1 		$220K Buy
+12,811
New +$239K ﹤0.01% 1836
2019
Q2 		– Sell
-53,560
Closed -$590K – 1356
2019
Q1 		$590K Buy
+53,560
New +$434K 0.04% 284

Other funds holding XBIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

ExodusPoint Capital Management's XBIT Position: Q2 2024 in Review

ExodusPoint Capital Management sold out of XBiotech (XBIT) in Q2 2024, closing a stake of 16,177 shares — an estimated $132K sold.

ExodusPoint Capital Management first reported a position in XBIT in Q1 2019 and held it in 3 quarters. The position peaked at $590K in Q1 2019. 46 funds tracked by Wall St. Rank hold XBIT as of Q2 2024.

  • ExodusPoint Capital Management reported no remaining XBiotech position as of Q2 2024 after selling out during the quarter.
  • ExodusPoint Capital Management sold 16,177 XBiotech shares in Q2 2024, an estimated $132K.
  • ExodusPoint Capital Management first reported a position in XBiotech in Q1 2019 and held it in 3 quarters.
  • ExodusPoint Capital Management's XBiotech position peaked at $590K in Q1 2019.
  • 46 funds tracked by Wall St. Rank held XBiotech as of Q2 2024.

Based on ExodusPoint Capital Management's 13F filing for Q2 2024, filed 13 Aug 2024.